247 related articles for article (PubMed ID: 32152526)
1. Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China.
Chen L; Lin J; Lu H; Zhang X; Wang C; Liu H; Zhang X; Li J; Cao J; Zhou T
J Antibiot (Tokyo); 2020 Jul; 73(7):463-470. PubMed ID: 32152526
[TBL] [Abstract][Full Text] [Related]
2. Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital.
Thet KT; Lunha K; Srisrattakarn A; Lulitanond A; Tavichakorntrakool R; Kuwatjanakul W; Charoensri N; Chanawong A
World J Microbiol Biotechnol; 2020 Jul; 36(7):102. PubMed ID: 32613355
[TBL] [Abstract][Full Text] [Related]
3. Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolate.
Machado D; Antunes J; Simões A; Perdigão J; Couto I; McCusker M; Martins M; Portugal I; Pacheco T; Batista J; Toscano C; Viveiros M
J Med Microbiol; 2018 Jun; 67(6):740-749. PubMed ID: 29717972
[TBL] [Abstract][Full Text] [Related]
4. Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii.
Çağlan E; Nigiz Ş; Sancak B; Gür D
Acta Microbiol Immunol Hung; 2020 Jun; 67(2):107-111. PubMed ID: 31813259
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
Lo-Ten-Foe JR; de Smet AM; Diederen BM; Kluytmans JA; van Keulen PH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3726-30. PubMed ID: 17646414
[TBL] [Abstract][Full Text] [Related]
6. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.
Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654
[TBL] [Abstract][Full Text] [Related]
7. Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii.
Jo J; Ko KS
Microbiol Spectr; 2021 Oct; 9(2):e0101021. PubMed ID: 34523993
[TBL] [Abstract][Full Text] [Related]
8. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.
Li J; Rayner CR; Nation RL; Owen RJ; Spelman D; Tan KE; Liolios L
Antimicrob Agents Chemother; 2006 Sep; 50(9):2946-50. PubMed ID: 16940086
[TBL] [Abstract][Full Text] [Related]
9. Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran.
Ezadi F; Jamali A; Heidari A; Javid N; Ardebili A
J Glob Antimicrob Resist; 2020 Jun; 21():380-385. PubMed ID: 31770604
[TBL] [Abstract][Full Text] [Related]
10. Two types of colistin heteroresistance in
Hong YK; Kim H; Ko KS
Emerg Microbes Infect; 2020 Dec; 9(1):2114-2123. PubMed ID: 32897166
[TBL] [Abstract][Full Text] [Related]
11. Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment.
Jo J; Kwon KT; Ko KS
J Biomed Sci; 2023 Jun; 30(1):37. PubMed ID: 37287044
[TBL] [Abstract][Full Text] [Related]
12. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
[TBL] [Abstract][Full Text] [Related]
13. Discrepancies in susceptibility testing to colistin in Acinetobacter baumannii: The influence of slow growth and heteroresistance.
Rodriguez CH; Traglia G; Bastias N; Pandolfo C; Bruni G; Nastro M; Barrios R; Bavastro EM; Rey MC; Marques IA; Heger F; Vay C; Fernandez JS; Ramirez MS; Famiglietti A
Int J Antimicrob Agents; 2019 Nov; 54(5):587-591. PubMed ID: 31400469
[TBL] [Abstract][Full Text] [Related]
14. Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates.
Srinivas P; Hunt LN; Pouch SM; Thomas K; Goff DA; Pancholi P; Balada-Llasat JM; Bauer KA
Diagn Microbiol Infect Dis; 2018 Jun; 91(2):194-198. PubMed ID: 29482871
[TBL] [Abstract][Full Text] [Related]
15. Emergence of eravacycline heteroresistance in carbapenem-resistant
Li YT; Chen XD; Guo YY; Lin SW; Wang MZ; Xu JB; Wang XH; He GH; Tan XX; Zhuo C; Lin ZW
Front Cell Infect Microbiol; 2024; 14():1356353. PubMed ID: 38601741
[TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
Piewngam P; Kiratisin P
Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
[TBL] [Abstract][Full Text] [Related]
17. [Comparative evaluation of the sensitivity of Acinetobacter to colistin, using the prediffusion and minimum inhibitory concentration methods: detection of heteroresistant isolates].
Herrera ME; Mobilia LN; Posse GR
Rev Argent Microbiol; 2011; 43(2):115-9. PubMed ID: 21731974
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of Tn6018-3' CS regions increases colistin MICs against Acinetobacter baumannii isolates harboring new variants of AbaRs.
Savari M; Ekrami A; Shoja S; Bahador A
Folia Microbiol (Praha); 2017 Sep; 62(5):373-379. PubMed ID: 28238067
[TBL] [Abstract][Full Text] [Related]
19. Colistin heteroresistance in acinetobacter and its association with previous colistin therapy.
Hawley JS; Murray CK; Jorgensen JH
Antimicrob Agents Chemother; 2008 Jan; 52(1):351-2. PubMed ID: 17954699
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
